Intrinsic Value of S&P & Nasdaq Contact Us

Indivior PLC INVVY OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
62/100
4/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Indivior PLC (INVVY) trades at a trailing P/E of 13.3. Trailing earnings yield is 7.51%.

Criteria proven by this page:

  • VALUE (85/100, Pass) — P/E is below market average (13.3); earnings yield beats bond yields (7.51%).
  • Trailing Earnings Yield 7.51% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.

Overall SharesGrow Score: 62/100 with 4/7 criteria passed.

SharesGrow 7-Criteria Score
62/100
SG Score
View full scorecard →
VALUE
85/100
Price-to-Earnings & upside
Proven by this page
FUTURE
20/100
Analyst consensus
→ Forecast
~
PAST
75/100
→ Income
HEALTH
25/100
Debt-to-Equity & liquidity
→ Health
MOAT
70/100
→ Income
GROWTH
90/100
→ Income
INCOME
70/100
→ Income

Valuation Snapshot — INVVY

Valuation Multiples
P/E (TTM)13.3
Forward P/EN/A
PEG Ratio0.00
Forward PEGN/A
P/B Ratio0.00
P/S Ratio2.26
EV/EBITDA0.0
Per Share Data
EPS (TTM)$1.64
Book Value / Share$0.00
Revenue / Share$9.68
FCF / Share$0.00
Yields & Fair Value
Earnings Yield7.51%
Dividend Yield0.00%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $0.22 $968.89M $32.05M 3.3%
2017 $0.41 $1.15B $60.92M 5.3%
2018 $1.75 $959.92M $262.67M 27.4%
2019 $0.92 $815.16M $139.15M 17.1%
2020 $-1.08 $689.68M $-157.76M -22.9%
2021 $1.31 $777.48M $205M 26.4%
2022 $-0.37 $884.63M $-52.04M -5.9%
2023 $0.01 $1.09B $2M 0.2%
2024 $0.02 $1.19B $2M 0.2%
2025 $1.64 $1.24B $210M 16.9%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message